The blood/cerebrospinal fluid partitioning of pyrazinamide: a study during the course of treatment of tuberculous meningitis.
Concentrations of pyrazinamide were measured in serum and cerebrospinal fluid (CSF) of 17 adult patients with tuberculous meningitis up to six months after starting treatment. Pyrazinamide penetrated excellently into the CSF and mean concentrations at various intervals up to six months of treatment were consistently above that required for inhibition of the growth of Mycobacterium tuberculosis. The blood/CSF partitioning of pyrazinamide does not change as the patients recover from the meningitis.
Phuapradit
P
P
Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Supmonchai
K
K
Kaojarern
S
S
Mokkhavesa
C
C
D000293:Adolescent; D000328:Adult; D000368:Aged; D000995:Antitubercular Agents / Q000627:therapeutic use; D001812:Blood-Brain Barrier / Q000502:physiology*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011718:Pyrazinamide / Q000493:pharmacokinetics* / Q000627:therapeutic use; D014390:Tuberculosis, Meningeal / Q000134:cerebrospinal fluid* / Q000188:drug therapy
D000995:Antitubercular Agents; D011718:Pyrazinamide